Evidence map›Paper›PMID 41123288›Full record

SynthesisJournal of the National Cancer Institute2026

Redefining neurocognitive outcomes after radiation for brain metastases: a patient-level meta-analysis of recovery following initial decline.

Hua-Ren R Cherng, Kai Sun, Soren M Bentzen, Paul D Brown, Terri S Armstrong, Joshua D Palmer, Vinai Gondi, Minesh P Mehta, Mark V Mishra

Abstract readMeta-Analysis
In one paragraph

Synthesis in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hua-Ren R CherngDepartment of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD, United States.ORCID 0000-0002-4817-1007
Kai SunDivision of Biostatistics and Bioinformatics, University of Maryland Greenebaum Cancer Center, Baltimore, MD, United States.ORCID 0009-0002-7959-7171
Soren M BentzenDivision of Biostatistics and Bioinformatics, University of Maryland Greenebaum Cancer Center, Baltimore, MD, United States.ORCID 0000-0002-7444-7564
Paul D BrownDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, United States.
Terri S ArmstrongNational Cancer Institute Center for Cancer Research, National Institutes of Health, Bethesda, MD, United States.ORCID 0000-0002-2414-0492
Joshua D PalmerDepartment of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.ORCID 0000-0003-3311-0129
Vinai GondiDepartment of Radiation Oncology, Northwestern Medicine Cancer Center and Proton Center, Warrenville, IL, United States.
Minesh P MehtaDepartment of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, United States.ORCID 0000-0002-4812-5713
Mark V MishraDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States.ORCID 0000-0002-2588-1575

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Proposal for NCI Research Specialist (Clinician Scientist) AwardR50CA305013 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI MISHRA, MARK V. · 2025 to 2025
$375k
NCI NIH HHS P30 CA134274NCI NIH HHS P30CA134274NCI NIH HHS R50 CA305013NIH HHS
6 · The paper itself

Abstract

backgroundAlthough there are data describing the onset of neurocognitive toxicity following radiation for patients with brain metastases, less is known about the potential for functional cognitive recovery (CR). This study sought to evaluate CR following neurocognitive function failure (NCF) in patients treated with stereotactic radiosurgery (SRS), whole-brain radiotherapy (WBRT), and hippocampal avoidance (HA)-WBRT.

methodsA pooled analysis of 3 (NCCTG N107C/CEC.3, NCCTG N0574, and NRG CC001) clinical trials was performed. Patients with trial-defined NCF and longitudinal cognitive testing were included. The primary endpoint was time to CR, defined as patients no longer exhibiting a 1 or more standard deviation decline from baseline on any cognitive test.

resultsA total of 288 patients were included, with a median follow-up of 12.2 months. The cumulative incidence of CR was 38% (95% confidence interval [CI] = 32.5% to 43.9%) at 6 months after NCF. Incidence of CR was significantly improved with post-op SRS vs WBRT (hazard ratio [HR] = 2.68, 95% CI = 1.43 to 5.03, P = .002) and with SRS vs SRS+WBRT (HR = 2.35, 95% CI = 1.16 to 4.79, P = .008). On multivariable analysis, SRS was highly prognostic of CR compared with WBRT (HR = 2.42, 95% CI = 1.70 to 3.45, P < .0001). Meta-analysis demonstrated that conformal RT techniques (SRS or HA-WBRT) conferred a significantly higher rate of CR compared with WBRT (pooled HR = 2.12, 95% CI = 1.49 to 3.02, P < .001); 68% of patients had long-term sustained CR.

conclusionsA sizeable proportion of patients who experience NCF following brain radiation eventually attain full and sustained CR, thereby highlighting that neurocognitive decline may not be permanent. The use of conformal radiation techniques results in greater rates of neurocognitive recovery.

Indexed as

Brain NeoplasmsCognitionCranial IrradiationRadiosurgeryAgedFemaleHumansMaleMiddle AgedRadiation InjuriesRecovery of FunctionTreatment Outcome

Identifiers

PMID41123288
PMCPMC13396261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.